Literature DB >> 12776164

Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.

Q Yao1, S Wang, A Gambotto, J C Glorioso, C H Evans, P D Robbins, S C Ghivizzani, T J Oligino.   

Abstract

Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that primarily affects joints. In rheumatoid joints there is extensive synovial proliferation with diseased synovium becoming highly aggressive, attaching to the articular cartilage and bone to form what is termed a pannus. The formation of active pannus is central to erosive disease and resulting joint destruction. In this study, we examined the ability to eliminate the hyperplastic synovium by adenoviral-mediated gene transfer of human TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF family that is able to induce apoptosis through interaction with receptors containing death domains, DR4 and DR5. Infection of synovial cells derived from RA patients with Ad.TRAIL resulted in significant apoptosis in three out of five lines. Moreover, primary rabbit synovial fibroblasts were also sensitive to Ad.TRAIL-mediated gene transfer. In a rabbit model of arthritis, intra-articular gene transfer of TRAIL induced apoptosis in cells within the synovial lining, reduced leukocytic infiltration and stimulated new matrix synthesis by cartilage. These results demonstrate that TRAIL can affect the viability of the cells populating the activated synovium in arthritic joints and suggest that the delivery of TRAIL to arthritic joints may represent a non-invasive mechanism for inducing pannus regression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776164     DOI: 10.1038/sj.gt.3301881

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  17 in total

1.  A novel angiographic methodology for the quantification of angiogenesis.

Authors:  Matthew J Gounis; Baruch B Lieber; Keith A Webster; Ajay K Wakhloo
Journal:  IEEE Trans Biomed Eng       Date:  2008-03       Impact factor: 4.538

Review 2.  TNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what's new?

Authors:  Anna Neve; Addolorata Corrado; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2012-12-30       Impact factor: 3.984

3.  Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis.

Authors:  A Jüngel; V Baresova; C Ospelt; B R Simmen; B A Michel; R E Gay; S Gay; C A Seemayer; M Neidhart
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

4.  Preclinical efficacy of sodium narcistatin to reduce inflammation and joint destruction in rats with adjuvant-induced arthritis.

Authors:  Cheri Lubahn; Jill A Schaller; Eric Shewmacker; Carlo Wood; Denise L Bellinger; Donna Byron; Noeleen Melody; George R Pettit; Dianne Lorton
Journal:  Rheumatol Int       Date:  2011-12-09       Impact factor: 2.631

5.  Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.

Authors:  Xinwen Yang; Jianhua Wang; Cunren Liu; William E Grizzle; Shaohua Yu; Shuangqin Zhang; Stephen Barnes; William J Koopman; John D Mountz; Robert P Kimberly; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

6.  The TRAIL to arthritis.

Authors:  George C Tsokos; Maria Tsokos
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis.

Authors:  Zhongyu Liu; Xin Xu; Hui-Chen Hsu; Albert Tousson; Ping-Ar Yang; Qi Wu; Cunren Liu; Shaohua Yu; Huang-Ge Zhang; John D Mountz
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

8.  TRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritis.

Authors:  Atil Bisgin; Ender Terzioglu; Cigdem Aydin; Burcak Yoldas; Veli Yazisiz; Nilufer Balci; Huseyin Bagci; Reginald M Gorczynski; Cezmi A Akdis; Salih Sanlioglu
Journal:  BMC Musculoskelet Disord       Date:  2010-08-27       Impact factor: 2.362

Review 9.  Perspectives on the use of gene therapy for chronic joint diseases.

Authors:  Steven C Ghivizzani; Elvire Gouze; Jean-Noel Gouze; Jesse D Kay; Marsha L Bush; Rachael S Watson; Padraic P Levings; David M Nickerson; Patrick T Colahan; Paul D Robbins; Christopher H Evans
Journal:  Curr Gene Ther       Date:  2008-08       Impact factor: 4.391

Review 10.  Concepts in gene therapy for cartilage repair.

Authors:  Andre F Steinert; Ulrich Nöth; Rocky S Tuan
Journal:  Injury       Date:  2008-04       Impact factor: 2.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.